Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments
Sbarro Health Research Organization (SHRO)Researchers have tagged two new potential targets for treating rhabdomyosarcoma (RMS) -- a highly malignant pediatric tumor thought to arise from mesenchymal stem cells (MSCs) committed to become skeletal muscle cells.